Back to search

Peptide record

TPDB15734

Antibacterial Anticancer Toxicity modified_plain modified
17 source-reported length (unverified)
Basic Information
TPDB15734
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
dbAMP DRAMP Peptipedia
modified_plain
Yes
A modified multi-activity (Antibacterial, Anticancer, and Toxicity) peptide record curated from dbAMP, DRAMP, and Peptipedia, without an available 3D structural model. Source-reported length: 17 (unverified).
Modified, details unspecified
Sequence
GIKKFLKSXKKFVKXFK

Source notation is retained verbatim; residue notation and chemical identity have not been independently validated. The displayed length is source-reported and unverified.

Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
17 source-reported length (unverified)
Evidence Records 3 records
Evidence 1 Activity

Activity

50% Hemolysis
Toxicity
50 µM
Hemolytic Cytotoxic
50% Hemolysis | 50 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Development of Amphipathic Antimicrobial Peptide Foldamers Based on Magainin 2 Sequence | ChemMedChem | 2019
Evidence 2 Activity

Activity

50% Hemolysis
Toxicity
3 µM
Hemolytic Cytotoxic
50% Hemolysis | 3 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Development of Amphipathic Antimicrobial Peptide Foldamers Based on Magainin 2 Sequence | ChemMedChem | 2019
Evidence 3 Activity

Activity

Toxicity
Hemolytic
Hemolytic_activity: [Ref.33466998] It has hemolysis against human red blood cells at 50 µM

Target

erythrocytes

Source & Reference

NA
DRAMP
Molecules. 2021 Jan 16 26(2):444. doi: 10.3390/molecules26020444.